4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-24-033704
Options or other derivatives
- Chief Financial Officer acquired 166,680 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Foster Jonathan P. Chief Financial Officer | 2024-11-04 | Grant or award · Stock option (right to buy) | +65,000 | 129,837 | D | ||
| Foster Jonathan P. Chief Financial Officer | 2024-11-04 | Grant or award · Restricted Stock Units | +82,500 | 212,337 | D | ||
| Foster Jonathan P. Chief Financial Officer | 2024-10-25 | Grant or award · Performance Based Restricted Stock Units | +19,180 | 231,517 | D | ||
Loading xslF345X05/rdgdoc.xml…